APA-čujuhus (7. p.)

Rong, Z., Li, L., Fei, F., Luo, L., & Qu, Y. (2025). Retraction Note: Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer. BMC.

Chicago-čujuhus (17. p.)

Rong, Zhe, Li Li, Fei Fei, Lailong Luo, juo Yang Qu. Retraction Note: Combined Treatment of Glibenclamide and CoCl2 Decreases MMP9 Expression and Inhibits Growth in Highly Metastatic Breast Cancer. BMC, 2025.

MLA-čujuhus (9. p.)

Rong, Zhe, et al. Retraction Note: Combined Treatment of Glibenclamide and CoCl2 Decreases MMP9 Expression and Inhibits Growth in Highly Metastatic Breast Cancer. BMC, 2025.

Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.